查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1564044

乳房病變定位全球市場

Breast Lesion Localization
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

至2030年，全球乳房病變定位市場預計將達到4.302億美元

Masu 表示，2023 年全球乳房病變定位市場預計為 3.158 億美元，預計到 2030 年將達到 4.302 億美元，2023-2030 年的複合年成長率為 4.5%。乳房切片是本報告分析的細分市場之一，複合年成長率為 5.0%，預計到分析期結束時將達到 3.092 億美元。在分析期間，燈切除術領域的複合年成長率估計為 3.3%。

美國市場預估為8,580萬美元，中國預期複合年成長率為4.2%

到 2023 年，美國乳房病變定位市場預計將達到 8,580 萬美元。中國作為世界第二大經濟體，預計到 2030 年市場規模將達到 6,780 萬美元，2023-2030 年分析期間複合年成長率為 4.2%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 4.3% 和 3.7%。在歐洲，德國的複合年成長率預計約為 4.5%。

全球乳房病變局部市場 - 主要趨勢和促進因素總結

為什麼乳房病變的定位在現代醫學中很重要？

乳房病變的定位是乳癌治療的重要步驟，尤其是早期檢測和治療計劃。但這個程序涉及什麼？基本上，它標記乳房組織內的可疑區域，以在切片檢查或手術期間指導外科醫生。隨著全球乳癌發生率的增加，準確定位的重要性只會越來越高。傳統方法，例如透過插入導線來標記病灶的導線定位，已經使用了數十年，但正在被更先進的技術所取代。這些新方法更加精確、不那麼不舒服，並且可以更有效地針對小的或不可觸及的病變，從而大大改善患者的治療效果。借助超音波、乳房X光攝影和磁振造影（MRI）等先進技術指南這些手術，醫療界比以往任何時候都更有能力進行有針對性的干涉，最大限度地減少組織損傷並提高康復率。

乳房病灶定位技術有哪些進展？

近年來，乳房病變定位技術取得了重大進展。從歷史上看，線導定位（WGL）一直是黃金標準。然而，雷達定位、RFID（無線射頻識別）和磁種子等無線定位技術的出現，提供了更簡化和高效的程序。例如，雷達照射使用雷達波精確瞄準病變，而不會帶來與電線相關的不適或限制。 RFID標籤是植入病變部位的小型標籤，可以長時間留在原處，從而實現更靈活的調度。另一種創新方法是磁性種子定位，涉及將小的磁性種子插入病變中，在手術過程中可以輕鬆檢測到。這些技術對於無法觸及病變的患者特別有益，減少了因錯誤觸診而重新手術的需要，並提高了患者體驗和醫生的準確性。向侵入性較小、更精確的技術的轉變凸顯了個人化醫療的更廣泛趨勢，其中精確性和患者舒適度至關重要。

不斷變化的指南和患者需求如何影響乳房病變的定位？

乳房病變定位的臨床前景正在受到幾個重要趨勢的影響，包括醫療指南的更新和患者期望的變化。美國乳房外科醫師協會（ASBrS）等組織的指引強調需要進行最小切緣的局部切除，這直接影響局部切除方法的選擇。外科醫生擴大尋求能夠提供即時回饋、提高精度並確保切除惡性組織的高可信度的技術。隨著患者尋求侵入性較小的治療方法以減少焦慮和不適，以患者為中心的照護也成為關鍵因素。對更靈活的調度和縮短時間的需求刺激了消除傳統線引導定位限制的技術的採用，其中定時對於確保線穩定性至關重要。因此，可以在手術前幾天植入的無線立體定位技術為患者和醫療保健提供者提供了便利和安心。

乳房病變定位市場的主要成長動力是什麼？

乳房病變定位市場的成長是由多種因素推動的，反映出對更先進和患者友善技術的需求不斷成長。首先，RFID、磁性種子和雷達等無線定位方法的技術進步提高了準確性和病患舒適度，促使醫療機構採用這些創新。其次，全球乳癌發生率不斷上升，增加了對精確定位技術作為早期檢測和治療策略一部分的需求。第三，不斷發展的醫療保健政策和對基於價值的護理的日益關注正在鼓勵醫院投資於能夠提供更好的結果、更少的併發症並符合現代醫療保健報銷模式的技術。此外，新興國家的人口老化和乳癌篩檢率的提高正在為市場開拓創造新的機會。最後，患者對微創手術和允許更靈活安排的技術的偏好正在加速遠離線引導技術，進一步推動對創新乳房病變定位解決方案的需求。這些因素共同改變了乳房病變定位的格局，並創造了一個優先考慮技術進步、患者體驗和改善臨床結果的市場。

調查企業範例（共43例）

  • Argon Medical Devices, Inc.
  • BARD, A Becton, Dickinson Company
  • Cianna Medical, Inc.
  • Cook Medical LLC
  • CP Medical Corporation
  • Somatex Medical Technologies GmbH
  • Sterylab Srl

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他領域

第4章 比賽

簡介目錄
Product Code: MCP10796

Global Breast Lesion Localization Market to Reach US$430.2 Million by 2030

The global market for Breast Lesion Localization estimated at US$315.8 Million in the year 2023, is expected to reach US$430.2 Million by 2030, growing at a CAGR of 4.5% over the analysis period 2023-2030. Breast Biopsy, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$309.2 Million by the end of the analysis period. Growth in the Lumpectomy segment is estimated at 3.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$85.8 Million While China is Forecast to Grow at 4.2% CAGR

The Breast Lesion Localization market in the U.S. is estimated at US$85.8 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$67.8 Million by the year 2030 trailing a CAGR of 4.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.3% and 3.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Global Breast Lesion Localization Market - Key Trends and Drivers Summarized

Why Is Breast Lesion Localization Critical in Modern Medicine?

Breast lesion localization is a vital step in the management of breast cancer, especially for early detection and treatment planning. But what does this procedure entail? Essentially, it involves marking suspicious areas within the breast tissue to guide surgeons during biopsy or surgery. As breast cancer rates rise globally, the importance of accurate localization methods has only increased. Traditional methods such as wire localization, where a wire is inserted to mark the lesion, have been used for decades but are being phased out in favor of more advanced techniques. These new approaches offer higher precision, less discomfort, and more effective targeting of smaller or non-palpable lesions, greatly enhancing patient outcomes. With evolving technologies like ultrasound, mammography, and magnetic resonance imaging (MRI) guiding these procedures, the medical community is better equipped than ever to perform targeted interventions, minimizing damage to surrounding tissues and improving recovery rates.

What Are The Advancements in Breast Lesion Localization Technology?

In recent years, breast lesion localization technologies have undergone significant evolution. Historically, wire-guided localization (WGL) was the gold standard. However, non-wire alternatives like radar localization, radiofrequency identification (RFID), and magnetic seeds have emerged, offering more streamlined and efficient procedures. For instance, radar localization uses radar waves to precisely target lesions without the discomfort or limitations associated with wires. RFID tags, which involve implanting a small tag into the lesion, allow for more flexible scheduling as they can remain in place for longer periods. Magnetic seed localization, another innovative method, involves inserting a small magnetic seed into the lesion, which can then be easily detected during surgery. These technologies are especially beneficial for patients with non-palpable lesions, reducing the need for repeated surgeries due to mislocalization and enhancing both the patient's experience and the physician’s accuracy. The shift toward minimally invasive, highly accurate techniques underscores a broader trend in personalized medicine, where precision and patient comfort are paramount.

How Are Changing Guidelines and Patient Needs Shaping Breast Lesion Localization?

The clinical landscape for breast lesion localization has been shaped by several key trends, including updated medical guidelines and changing patient expectations. Guidelines from organizations like the American Society of Breast Surgeons (ASBrS) emphasize the need for localized excision with minimal margins, which directly impacts the choice of localization methods. Surgeons are increasingly seeking techniques that provide real-time feedback, enhance accuracy, and ensure a high degree of confidence in the excision of malignant tissue. Patient-centric care has also emerged as a defining factor, as patients seek minimally invasive options that reduce anxiety and procedural discomfort. The demand for more flexible scheduling and reduced time between diagnosis and surgery has spurred the adoption of technologies that eliminate the constraints imposed by traditional wire-guided localization, where timing was critical to ensure wire stability. As a result, non-wire localization methods, which can be implanted days before surgery, provide more convenience and peace of mind for both patients and healthcare providers.

What Are The Key Growth Drivers In The Breast Lesion Localization Market?

The growth in the breast lesion localization market is driven by several factors, reflecting the increasing demand for more advanced, patient-friendly technologies. First, technological advancements in non-wire localization methods, such as RFID, magnetic seeds, and radar, have improved both accuracy and patient comfort, pushing healthcare facilities to adopt these innovations. Second, the rising incidence of breast cancer globally has led to a greater need for precise localization techniques as part of early detection and treatment strategies. Third, evolving healthcare policies and the increasing focus on value-based care have encouraged hospitals to invest in technologies that offer better outcomes with fewer complications, aligning with modern medical reimbursement models. Additionally, the aging population and increased breast cancer screening rates in developing countries are creating new opportunities for market expansion. Lastly, patient preferences for minimally invasive procedures and technologies that allow for more flexible scheduling have accelerated the shift away from wire-guided methods, further driving the demand for innovative breast lesion localization solutions. Together, these factors are transforming the landscape of breast lesion localization, fostering a market that prioritizes technological advancements, patient experience, and improved clinical outcomes.

Select Competitors (Total 43 Featured) -

  • Argon Medical Devices, Inc.
  • BARD, A Becton, Dickinson Company
  • Cianna Medical, Inc.
  • Cook Medical LLC
  • CP Medical Corporation
  • Somatex Medical Technologies GmbH
  • Sterylab Srl

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Breast Lesion Localization - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Breast Cancer Globally Drives Demand for Accurate and Efficient Localization Technologies
    • Advancements in Non-Wire Localization Techniques Propel Growth in Breast Lesion Localization Market
    • Increased Adoption of Radiofrequency Identification (RFID) and Magnetic Seed Localization Expands Addressable Market Opportunities
    • Adoption of Image-Guided Localization Techniques Accelerates Market Growth
    • Growing Focus on Reducing Re-Excision Rates and Improving Surgical Outcomes Propels Demand for Advanced Localization Tools
    • Surge in Demand for Targeted Breast Surgeries and Personalized Treatment Plans Drives Adoption of Localization Technologies
    • Here's How Advances in Magnetic Seed and Radar Localization Techniques are Creating New Market Opportunities
    • Increased Awareness of Breast Cancer Screening Programs Globally Generates New Opportunities for Localization Technologies
    • Rising Adoption of RFID Localization in Complex Breast Surgeries Spurs Technological Innovation
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Breast Lesion Localization Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Breast Lesion Localization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World 7-Year Perspective for Breast Lesion Localization by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Breast Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World 7-Year Perspective for Breast Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Lumpectomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 7: World 7-Year Perspective for Lumpectomy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Wire Localization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World 7-Year Perspective for Wire Localization by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Magnetic Localization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World 7-Year Perspective for Magnetic Localization by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Radioisotope Localization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 13: World 7-Year Perspective for Radioisotope Localization by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Method Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World 7-Year Perspective for Other Method Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Breast Lesion Localization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 16: USA Recent Past, Current & Future Analysis for Breast Lesion Localization by Usage - Breast Biopsy and Lumpectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 17: USA 7-Year Perspective for Breast Lesion Localization by Usage - Percentage Breakdown of Value Sales for Breast Biopsy and Lumpectomy for the Years 2024 & 2030
    • TABLE 18: USA Recent Past, Current & Future Analysis for Breast Lesion Localization by Method Type - Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 19: USA 7-Year Perspective for Breast Lesion Localization by Method Type - Percentage Breakdown of Value Sales for Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types for the Years 2024 & 2030
  • CANADA
    • TABLE 20: Canada Recent Past, Current & Future Analysis for Breast Lesion Localization by Usage - Breast Biopsy and Lumpectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Canada 7-Year Perspective for Breast Lesion Localization by Usage - Percentage Breakdown of Value Sales for Breast Biopsy and Lumpectomy for the Years 2024 & 2030
    • TABLE 22: Canada Recent Past, Current & Future Analysis for Breast Lesion Localization by Method Type - Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 23: Canada 7-Year Perspective for Breast Lesion Localization by Method Type - Percentage Breakdown of Value Sales for Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types for the Years 2024 & 2030
  • JAPAN
    • Breast Lesion Localization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 24: Japan Recent Past, Current & Future Analysis for Breast Lesion Localization by Usage - Breast Biopsy and Lumpectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 25: Japan 7-Year Perspective for Breast Lesion Localization by Usage - Percentage Breakdown of Value Sales for Breast Biopsy and Lumpectomy for the Years 2024 & 2030
    • TABLE 26: Japan Recent Past, Current & Future Analysis for Breast Lesion Localization by Method Type - Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Japan 7-Year Perspective for Breast Lesion Localization by Method Type - Percentage Breakdown of Value Sales for Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types for the Years 2024 & 2030
  • CHINA
    • Breast Lesion Localization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 28: China Recent Past, Current & Future Analysis for Breast Lesion Localization by Usage - Breast Biopsy and Lumpectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 29: China 7-Year Perspective for Breast Lesion Localization by Usage - Percentage Breakdown of Value Sales for Breast Biopsy and Lumpectomy for the Years 2024 & 2030
    • TABLE 30: China Recent Past, Current & Future Analysis for Breast Lesion Localization by Method Type - Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 31: China 7-Year Perspective for Breast Lesion Localization by Method Type - Percentage Breakdown of Value Sales for Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types for the Years 2024 & 2030
  • EUROPE
    • Breast Lesion Localization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Breast Lesion Localization by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 33: Europe 7-Year Perspective for Breast Lesion Localization by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
    • TABLE 34: Europe Recent Past, Current & Future Analysis for Breast Lesion Localization by Usage - Breast Biopsy and Lumpectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 35: Europe 7-Year Perspective for Breast Lesion Localization by Usage - Percentage Breakdown of Value Sales for Breast Biopsy and Lumpectomy for the Years 2024 & 2030
    • TABLE 36: Europe Recent Past, Current & Future Analysis for Breast Lesion Localization by Method Type - Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 37: Europe 7-Year Perspective for Breast Lesion Localization by Method Type - Percentage Breakdown of Value Sales for Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types for the Years 2024 & 2030
  • FRANCE
    • Breast Lesion Localization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 38: France Recent Past, Current & Future Analysis for Breast Lesion Localization by Usage - Breast Biopsy and Lumpectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: France 7-Year Perspective for Breast Lesion Localization by Usage - Percentage Breakdown of Value Sales for Breast Biopsy and Lumpectomy for the Years 2024 & 2030
    • TABLE 40: France Recent Past, Current & Future Analysis for Breast Lesion Localization by Method Type - Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 41: France 7-Year Perspective for Breast Lesion Localization by Method Type - Percentage Breakdown of Value Sales for Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types for the Years 2024 & 2030
  • GERMANY
    • Breast Lesion Localization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 42: Germany Recent Past, Current & Future Analysis for Breast Lesion Localization by Usage - Breast Biopsy and Lumpectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 43: Germany 7-Year Perspective for Breast Lesion Localization by Usage - Percentage Breakdown of Value Sales for Breast Biopsy and Lumpectomy for the Years 2024 & 2030
    • TABLE 44: Germany Recent Past, Current & Future Analysis for Breast Lesion Localization by Method Type - Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Germany 7-Year Perspective for Breast Lesion Localization by Method Type - Percentage Breakdown of Value Sales for Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types for the Years 2024 & 2030
  • ITALY
    • TABLE 46: Italy Recent Past, Current & Future Analysis for Breast Lesion Localization by Usage - Breast Biopsy and Lumpectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 47: Italy 7-Year Perspective for Breast Lesion Localization by Usage - Percentage Breakdown of Value Sales for Breast Biopsy and Lumpectomy for the Years 2024 & 2030
    • TABLE 48: Italy Recent Past, Current & Future Analysis for Breast Lesion Localization by Method Type - Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 49: Italy 7-Year Perspective for Breast Lesion Localization by Method Type - Percentage Breakdown of Value Sales for Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types for the Years 2024 & 2030
  • UNITED KINGDOM
    • Breast Lesion Localization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 50: UK Recent Past, Current & Future Analysis for Breast Lesion Localization by Usage - Breast Biopsy and Lumpectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: UK 7-Year Perspective for Breast Lesion Localization by Usage - Percentage Breakdown of Value Sales for Breast Biopsy and Lumpectomy for the Years 2024 & 2030
    • TABLE 52: UK Recent Past, Current & Future Analysis for Breast Lesion Localization by Method Type - Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 53: UK 7-Year Perspective for Breast Lesion Localization by Method Type - Percentage Breakdown of Value Sales for Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types for the Years 2024 & 2030
  • REST OF EUROPE
    • TABLE 54: Rest of Europe Recent Past, Current & Future Analysis for Breast Lesion Localization by Usage - Breast Biopsy and Lumpectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 55: Rest of Europe 7-Year Perspective for Breast Lesion Localization by Usage - Percentage Breakdown of Value Sales for Breast Biopsy and Lumpectomy for the Years 2024 & 2030
    • TABLE 56: Rest of Europe Recent Past, Current & Future Analysis for Breast Lesion Localization by Method Type - Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Rest of Europe 7-Year Perspective for Breast Lesion Localization by Method Type - Percentage Breakdown of Value Sales for Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types for the Years 2024 & 2030
  • ASIA-PACIFIC
    • Breast Lesion Localization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 58: Asia-Pacific Recent Past, Current & Future Analysis for Breast Lesion Localization by Usage - Breast Biopsy and Lumpectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 59: Asia-Pacific 7-Year Perspective for Breast Lesion Localization by Usage - Percentage Breakdown of Value Sales for Breast Biopsy and Lumpectomy for the Years 2024 & 2030
    • TABLE 60: Asia-Pacific Recent Past, Current & Future Analysis for Breast Lesion Localization by Method Type - Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 61: Asia-Pacific 7-Year Perspective for Breast Lesion Localization by Method Type - Percentage Breakdown of Value Sales for Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types for the Years 2024 & 2030
  • REST OF WORLD
    • TABLE 62: Rest of World Recent Past, Current & Future Analysis for Breast Lesion Localization by Usage - Breast Biopsy and Lumpectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Rest of World 7-Year Perspective for Breast Lesion Localization by Usage - Percentage Breakdown of Value Sales for Breast Biopsy and Lumpectomy for the Years 2024 & 2030
    • TABLE 64: Rest of World Recent Past, Current & Future Analysis for Breast Lesion Localization by Method Type - Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 65: Rest of World 7-Year Perspective for Breast Lesion Localization by Method Type - Percentage Breakdown of Value Sales for Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types for the Years 2024 & 2030

IV. COMPETITION